NxGen_banner-01.png

Smart port.

Early detection.

Better outcomes.

THE NEXT GENERATION IN REMOTE PATIENT MONITORING

Advances in Personalized Medicine and Digital Health technologies are revolutionizing modern medicine. NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port efficacy with microchip and sensor technology, NGP measures, monitors and reports physiological body functions in vivo over the course of disease and treatment.

WHAT IS
NXGEN PORT?

bullet-01.png
bullet-01.png
bullet-01.png
bullet-01.png
bullet-01.png

Port efficacy + new sensor technology
 

Remotely measure real-time physiological distress
 

Digital health platform coordinating patients + providers
 

Early intervention
 

Patient management

waves_bg-01.png

THE 
PROBLEM

COSTS $2.3 BILLION ANNUALLY

50%

Of patients on chemo with a port suffer from neutropenia which puts them at greater risk for infection and complications

20%

Of patients have complications ranging from minor to major, most frequently infections and thrombosis, leading to port removal, hospitalization, higher medical costs and treatment

25%

Of women on trastuzumab for HER2+ breast cancer suffer cardiotoxicity and cardiac function decline

50%

Of patients have to delay or cancel treatment due to poor blood counts on treatment days

 

THE 
SOLUTION

solution-01.png
arrows-01.png

1

REMOTE MONITORING

Physiologic changes and trends measured in vivo.

solution-02.png
arrows-02.png

2

DATA + ANALYTICS

Real-time information about a patient's health status.

solution-03.png

3

REPORT TO PROVIDER

Relevant measures and actionable data.

solution-04.png

4

TAKE ACTION

Virtual patient management.

 

THE 
VALUE

NXgen Port PROVIDES EARLY 
INDICATION OF:
  • Infection

  • Changes in heart function

  • Blood cells counts

  • Oxygen levels

  • Body temperature

  • Proteins (i.e., hemoglobin)

  • Cancer prevalence

  • Device leakage or failure

value-01.png

PHYSICIANS

  • Early indication of infection
     

  • Remote patient monitoring
     

  • Put “eyes and hands” on patients
     

  • Actionable data
     

  • Maximize clinic time

value-02.png

PATIENTS

  • Baseline of health before treatment begins
     

  • Awareness of acceptable symptoms
     

  • Alert to infection Peace of mind
     

  • Limits “micro-traumas”

value-03.png

INSURANCE

PAYERS

  • Reduce unexpected hospitalizations
     

  • Manage costs due to adverse events

value-04.png

PROVIDERS

  • Reduce treatment cancelations or delays
     

  • Longitudinal data
     

  • Manage costs Increase efficiency

value-05.png

PHARMA

  • Virtual clinical trial support

  • Passive data collection
     

  • Adherence and drug efficacy

 
 

TEAM

Cathy Skinner, MA

Co-founder/Co-inventor

Chief Executive Officer

  • Entrepreneur with 10 years of startup experience (Thrivors.com and TheArtofWell.com).
     

  • Nationally recognized Cancer Exercise Specialist with the American College of Sports Medicine.
     

  • 12 years of working face-to-face with cancer patients and survivors providing wellness programs.
     

  • Invited panelist and guest speaker, Cancer Survivorship Conferences, Employer Benefits, Pharma Patient Advocacy conferences.
     

  • Former Chair of the Minnesota Cancer Alliance.
     

  • Board member with one non-profit organization.

Rosanne Welcher, PhD, MBA, RAC 

Co-founder/Co-inventor

Chief Science Officer

  • Award-winning R&D and Business Leader with cross-functional expertise in Medical Devices/IVD business development, product development, regulatory and clinical affairs, quality assurance, manufacturing and commercialization.
     

  • Over 25 years in med devices/IVD with people management experience.
     

  • Former CSO Agilent Technologies, Companion Diagnostics.
     

  • Invited guest speaker, Personalized Medicine, Regulatory/Clinical and IVD conferences.
     

  • 12 issued patents.
     

  • Board Director with two non-profit organizations.

Mohamed, M Ali, MD, PhD, RDCS

Co-inventor

Engineering and Research

  • Research Asst Professor, University of Illinois at Chicago.
     

  • Innovator, Biomedical Researcher and Instructor with 20 years’ experience in biomedical technology and cardiovascular medicine.
     

  • Founder and President, Vivotronix, Inc., providing remote clinical health care and rehabilitation.
     

  • 19 publications and one patent.

 

ADVISORS

Haddad Feb 2020.jpg

Tufia Haddad, MD

Oncology, Physician and
Patient Perspectives

  • Medical Director, Remote Patient Monitoring, Mayo Clinic Center for Digital Health.
     

  • Chair of Digital Health for the Department of Oncology.
     

  • Chair of the Breast Medical Oncology practice at Mayo Clinic.
     

  • Member of the Mayo Clinic Advisory Board to the Office of Artificial Intelligence.
     

  • 12+ years as medical oncologist.
     

  • Interests include precision medicine for breast cancer, cancer survivorship, and in the field of digital health, her interest is in the transformation of healthcare delivery models and development of advanced clinical decision support with novel connected health and AI technology solutions.
     

  • Research and education, providing mentorship to medical students, residents and fellows.

Nancy Lelicoff, BS, MS

Engineering and Management

Regulatory, Quality and Research

  • Healthcare consultant and advisor in regulatory strategy and operations.
     

  • 30+ years experience in the healthcare industry, across all aspects of medical device/IVD product development, registration and maintenance, with increasing levels of leadership.
     

  • Held executive level positions including former VP of Enterprise Regulatory Affairs, Quality Assurance, and Clinical and Medical Affairs for Agilent Technologies and Sr. VP of Regulatory Affairs, Quality Assurance and Systems Test Engineering for Volcano Corp (now Phillips).

team-04.png

Arvind Raghavan, PhD

Regulatory and Research

  • Cross-functional team leader with 15 years of experience managing the development and testing of therapeutics for multiple disease indications.
     

  • Demonstrated ability to foster collaborative approaches and innovative solutions, mindful of the big picture while focusing on operational efficiency.
     

  • Expertise in clinical trial design, monitoring, data analysis and regulatory requirements.

Unknown.jpeg

David Radloff

Financing and Strategy

  • 30 years of experience in finance, strategy, performance management and leadership
     

  • Experience in high growth environments as well as process optimization to improve profitability.
     

  • Former CFO at Hutchison Technology, Inc.
     

  • Significant experience in bank financing, secured and unsecured public debt as well as equity and equity related financings.
     

  • Strong relationships with numerous banks, investment banks, and investors.

 

CONTACT 
US

Tel: +1 651-587-5440

Saint Paul, MN USA

To submit a product or investor inquiry, please type your information here. We look forward to connecting with you.

Thanks for submitting!